Claravis
Product Images NDC 54868-6185

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Claravis (NDC 54868-6185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 30 mg Package Label (6185)

Packaging label for Claravis 30 mg capsules distributed by Physicians Total Care, Inc. in Tulsa, Oklahoma. The label includes lot number 000 and expiration date 01/60. Manufactured by PDR Laboratories, Inc., Porton NY 10979. A barcode for scanning is also present on the label.*

FDA Label Image

Image Of 20 mg Package Label (6307)

Label for Claravis 20 mg capsules distributed by Physicians Total Care, Inc. The label displays the lot number, expiration date (01/96), and includes a barcode. The product is identified with NDC 54808-6307-0 and contains 30 capsules.*

FDA Label Image

Image Of 40 mg Package Label (6308)

Label for Claravis 40 mg capsules showing the drug name and strength, labeler Physicians Total Care, Inc., lot number, expiration date, and a barcode. The label indicates a 30 capsule count.*

FDA Label Image

Chemical Structure (Cf93c87c 5417 4c5c Ac15 Dcfc35d5772b 01)

Chemical structure diagram of the active ingredient associated with Claravis, showing a molecular framework with rings and carboxylic acid functional group.*

FDA Label Image

Claravis 20 mg Capsules Prescription Blister 10s Pack, Part 1 Of 4 (Cf93c87c 5417 4c5c Ac15 Dcfc35d5772b 06)

Claravis 20 mg isotretinoin capsules packaging label from Physicians Total Care, Inc. The label includes multiple warnings stating 'Female patients: Do not get pregnant' and notes that the product causes birth defects. It features push-through blister packaging instructions and detailed directions for capsule removal, emphasizing protection from light and storage at controlled room temperature.*

FDA Label Image

Claravis 20 mg Capsules Prescription Blister 10s Pack, Part 2 Of 4 (Cf93c87c 5417 4c5c Ac15 Dcfc35d5772b 07)

Claravis 20 mg soft gelatin capsules prescription blister pack label by Barr Laboratories, Inc. The label states each capsule contains 20 mg isotretinoin and includes pregnancy warnings, dosage form, package size of 10 capsules, and instructions for female patients not to get pregnant. The label also displays the Barr logo, drug name, strength, and safety information prominently.*

FDA Label Image

Claravis 20 mg Capsules Prescription Blister 10s Pack, Part 3 Of 4 (Cf93c87c 5417 4c5c Ac15 Dcfc35d5772b 08)

Package insert box panel for Claravis by Physicians Total Care, Inc. The label includes important safety information for patients, emphasizing reading all materials provided, pregnancy precautions, and instructions not to take Claravis if pregnant. The text stresses understanding side effects, medication guides, and warnings about severe birth defects. It also covers manual problems, suicide warnings, and general patient guidance for safe use.*

FDA Label Image

Claravis 20 mg Capsules Prescription Blister 10s Pack, Part 4 Of 4 (Cf93c87c 5417 4c5c Ac15 Dcfc35d5772b 09)

Packaging label features an unfolded blister card layout for Claravis. The design shows positions for two columns of five capsules or tablets each, with outlined shapes indicating where the medication would be placed. The label is minimalist with a plain background and no visible active ingredient or strength text. The labeler is Physicians Total Care, Inc.*

FDA Label Image

Claravis 30 mg Capsules Prescription Blister 10s Pack, Part 1 Of 4 (Cf93c87c 5417 4c5c Ac15 Dcfc35d5772b 10)

Packaging label for Claravis 30 mg (isotretinoin capsules, USP) by Physicians Total Care, Inc. The label includes warnings for female patients about birth defects and pregnancy prevention, capsule dose and count layout, storage instructions, and detailed directions for removing each capsule. The label prominently features the phrase 'DO NOT GET PREGNANT' with multiple warning icons.*

FDA Label Image

Claravis 30 mg Capsules Prescription Blister 10s Pack, Part 2 Of 4 (Cf93c87c 5417 4c5c Ac15 Dcfc35d5772b 11)

Claravis 30 mg soft gelatin capsules prescription blister pack label. The product contains isotretinoin capsules, USP, each with 30 mg isotretinoin. The label is from Barr Laboratories, Inc., includes warnings about serious birth defects, and provides patient instructions emphasizing that female patients must not get pregnant while using this medication. The package size indicated is 10 capsules.*

FDA Label Image

Claravis 30 mg Capsules Prescription Blister 10s Pack, Part 3 Of 4 (Cf93c87c 5417 4c5c Ac15 Dcfc35d5772b 12)

Packaging label for Claravis, displaying important safety information and warnings for patients, especially female patients of childbearing potential. It includes instructions about the Medication Guide, patient consent forms, risks of birth defects, and guidelines on how to take the medication safely. The label emphasizes communication with healthcare providers and contains a warning section highlighted in red text.*

FDA Label Image

Claravis 30 mg Capsules Prescription Blister 10s Pack, Part 4 Of 4 (Cf93c87c 5417 4c5c Ac15 Dcfc35d5772b 13)

An instructional diagram depicting the organization or arrangement of capsules inside a packaging blister or tray. The image shows two columns, each containing six outlined capsule shapes, likely representing a 12-capsule count configuration for the product Claravis by Physicians Total Care, Inc.*

FDA Label Image

Claravis 40 mg Capsules Prescription Blister 10s Pack, Part 1 Of 4 (Cf93c87c 5417 4c5c Ac15 Dcfc35d5772b 14)

Claravis 40 mg isotretinoin capsules packaging label from Physicians Total Care, Inc. The label prominently displays warnings for female patients about birth defects and advises not to get pregnant. It includes instructions for safely removing each capsule using protective paper backing, with images showing peeling direction. The layout features capsule placement guidelines and clear pregnancy warnings.*

FDA Label Image

Claravis 40 mg Capsules Prescription Blister 10s Pack, Part 2 Of 4 (Cf93c87c 5417 4c5c Ac15 Dcfc35d5772b 15)

Claravis 40 mg soft gelatin capsules prescription blister pack label by Physicians Total Care, Inc. The label includes warnings for female patients on serious birth defects risks, detailed pregnancy-related precautions, and instructions to read accompanying DVD materials. It also has the Barr Laboratories logo and trademark information, with guidance for pharmacists to dispense intact packages only.*

FDA Label Image

Claravis 40 mg Capsules Prescription Blister 10 Pack, Part 3 Of 4 (Cf93c87c 5417 4c5c Ac15 Dcfc35d5772b 16)

Claravis packaging label by Physicians Total Care, Inc. featuring important safety information for patients, especially regarding birth defects, pregnancy prevention, and severe birth defects risk. The label emphasizes not taking Claravis if pregnant and outlines instructions to read the Medication Guide and sign an Informed Consent form before use. Contains warnings about side effects and instructions for patient compliance with safety programs.*

FDA Label Image

Claravis 40 mg Capsules Prescription Blister 10s Pack, Part 4 Of 4 (Cf93c87c 5417 4c5c Ac15 Dcfc35d5772b 17)

Inside packaging of Claravis showing die-cut slots for blister packs on both sides, designed to hold multiple rectangular tablets. Labeling visible on the inside flap is minimal, without legible text or branding. The product is associated with Physicians Total Care, Inc. as the labeler.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.